Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 27,930 | 21,915 | 24,621 | 16,425 | 19,526 |
| Cost of Goods | 14,998 | 15,001 | 15,008 | 11,308 | 13,780 |
| Gross Profit | 12,932 | 6,914 | 9,613 | 5,117 | 5,746 |
| Operating Expenses | 31,847 | 35,029 | 34,001 | 35,559 | 37,149 |
| Operating Income | -17,917 | -28,114 | -24,380 | -30,134 | -30,623 |
| Interest Expense | 678 | 664 | 644 | 625 | 628 |
| Other Income | 18,504 | -345 | 428 | 435 | 452 |
| Pre-tax Income | -91 | -29,123 | -24,596 | -30,324 | -30,799 |
| Net Income Continuous | -91 | -29,123 | -24,596 | -30,324 | -30,799 |
| Net Income | $-91 | $-29,123 | $-24,596 | $-30,324 | $-30,799 |
| EPS Basic Total Ops | 0.00 | -0.19 | -0.16 | -0.20 | -0.20 |
| EPS Basic Continuous Ops | 0.00 | -0.19 | -0.16 | -0.20 | -0.21 |
| EPS Diluted Total Ops | 0.00 | -0.19 | -0.16 | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | 0.00 | -0.19 | -0.16 | -0.20 | -0.21 |
| EBITDA(a) | $-15,173 | $-25,383 | $-21,920 | $-27,822 | $-28,929 |